Breast cancer is the most common cancer form in women and it has been extensively
studied on the molecular level. Male breast cancer (MBC), on the other hand, is rare and has …

Male breast cancer (MBC) is rare, accounting for less than 1% of all breast cancer but the
incidence has increased worldwide. Risk factors include increased longevity, obesity …

Male breast cancer (MBC) is a poorly characterized disease because of its rarity. Clinical
management is based on results obtained from randomized trials conducted in women …

Significant advances have been made in the diagnosis and treatment of female breast
cancer, resulting in a decline in incidence and a global improvement in clinical outcome …

The incidence of male breast cancer (MBC) is rising; however, mortality due to MBC has not
changed, unlike female breast cancer. This lack of change is mostly attributable to a lack of …

Abstract Purpose Male Breast Cancer (MBC) remains a poor understood disease.
Prognostic factors are not well established and specific prognostic subgroups are warranted …

Although breast cancer is uncommon in men, it can cause significant morbidity and mortality.
The current review was undertaken to determine whether strategies applied for the …

Background Male breast cancer (MBC) is a rare disease accounting for approximately 1% of
all breast carcinomas. Presently treatment recommendations are derived from the standards …

Background Male breast cancer (MBC) is rare. Molecular subtype has been utilized widely
in female breast cancer. But the relationship between subtype and prognosis in MBC …

Background. Male breast cancer (MBC) is an uncommon disease and there is limited
information on the prognostic impact of routinely used clinicopathological parameters …